Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06924489

Advanced Adenoma Detection With 3D Imaging Device During Colonoscopy

Effect of 3-Dimensional Imaging Device on Advanced Adenoma Detection During Colonoscopy: A Multi-center Randomized Controlled Trial

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
1,566 (estimated)
Sponsor
Xijing Hospital of Digestive Diseases · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

The goal of this clinical trial is to learn if 3-dimensional (3D) imaging device works to identify patients with high risk adenomas during colonoscopy to guide proper follow-up strategy. It will also learn about the safety of 3-dimensional (3D) imaging device. The main questions it aims to answer are: Does 3-dimensional (3D) imaging device improve the identification of patients with high risk adenomas? What adverse events do participants experience during colonoscopy? Researchers will compare 3-dimensional (3D) imaging device to traditional 2-dimensional (2D) imaging device to see if 3-dimensional (3D) imaging device works to improve high risk adenoma identification. Participants will: Undertake colonoscopy examination using 3-dimensional (3D) imaging device or 2-dimensional (2D) imaging device. Be followed-up to 30 days to record potential colonoscopy-relevant adverse events.

Conditions

Interventions

TypeNameDescription
PROCEDUREColonoscopy after bowel cleansing with 2D imaging deviceparticipants will undergo colonoscopy examination using 2D imaging colonoscope to detect potential adenomas or polyps. The classification of the detected lession will be determined by the edoscopic diagnosis based on the JNET classification system or by the pathological diagnosis with tissues from biopsy or polypectomy.
PROCEDUREColonoscopy after bowel cleansing with 3D imaging deviceparticipants will undergo colonoscopy examination using 3D imaging colonoscope to detect potential adenomas or polyps. The classification of the detected lession will be determined by the edoscopic diagnosis based on the JNET classification system or by the pathological diagnosis with tissues from biopsy or polypectomy.

Timeline

Start date
2025-06-01
Primary completion
2026-06-01
Completion
2026-07-01
First posted
2025-04-11
Last updated
2025-04-11

Source: ClinicalTrials.gov record NCT06924489. Inclusion in this directory is not an endorsement.